CNS
BioStock Studio: Gabather gives clinical trial update
Gabather’s top candidate GT-002 for treating psychiatric or mood disorders like depression, anxiety, and schizophrenia is currently in the early...
BioStock TV
Intervju
Q4 report points to progress in the clinic for Gabather
Last week, Gabather published its 2020 year-end report,...
Gabather – focus on CNS diseases
Diseases of the central nervous system (CNS) and...
Upsher-Smith förlänger samarbetsavtal med Saniona
Sedan januari i år har danska Saniona ett...
